Showing 1,681 - 1,700 results of 62,059 for search '(( 5 ((ng decrease) OR (we decrease)) ) OR ( 50 ((a decrease) OR (nn decrease)) ))', query time: 1.28s Refine Results
  1. 1681
  2. 1682
  3. 1683
  4. 1684
  5. 1685
  6. 1686
  7. 1687
  8. 1688
  9. 1689

    Flow chart. by Raphaele Houlbracq (20558509)

    Published 2025
    “…The difference in overall prevalence of OASI between 2010 (0.7%) and 2021 (1.0%) was not statistically significant after adjustment (aRR 1.24, 95% CI 0.91 to 1.68). By groups of classification, the prevalence of OASI increased significantly only in Group 2b [nulliparous term cephalic singleton with spatula delivery] from 2.6% (95% CI 1.2 to 5.6) in 2010 to 9.6% (95% CI 6.2 to 14.7) in 2021 (aRR 3.69, 95% CI 1.50 to 9.09), and did not differ statistically significantly in Group 2a [nulliparous term cephalic singleton with forceps delivery] from 3.2% (95% CI 1.8 to 5.7) in 2010 to 5.7% (95% CI 3.4 to 9.5) in 2021 (aRR 1.78, 95% CI 0.81 to 3.90).…”
  10. 1690

    Data used to generate Fig 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  11. 1691

    Data used to generate Table 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  12. 1692
  13. 1693

    (R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

    Published 2011
    “…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”
  14. 1694
  15. 1695
  16. 1696
  17. 1697

    DataSheet_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.pdf by Yun Ji (464484)

    Published 2022
    “…However, the continuous virus evolution requires diverse mAb options to combat variants. Here we describe two fully human mAbs, amubarvimab (BRII-196) and romlusevimab (BRII-198) that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein and effectively neutralize SARS-CoV-2 variants. …”
  18. 1698

    Exogenous activation of BMP signaling decreases apoptosis in POb cells. by Shuli Li (24534)

    Published 2013
    “…<p>(A) Histogram illustrating a time-course of Caspase-3 activity performed on FOb and POb cells undergoing osteogenic differentiation with or without exogenous BMP-2 (200 ng/ml). BMP-2 treatment decreases apoptosis markedly in POb cells compared to untreated POb, a lower apoptotic activity is also observed in BMP-2 treated FOb as compared to untreated FOb cells. …”
  19. 1699

    DPT3 Stat EDHS for five surveys. by Hailu Fekadu (17797638)

    Published 2024
    “…Regarding educational status, inequality (RII) show decreasing pattern from 7.2% (2000) to 1.5% in(2019). …”
  20. 1700